Patents by Inventor Jan Terje Andersen

Jan Terje Andersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120322739
    Abstract: The invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The invention also relates to fusion polypeptides and conjugates comprising said variant albumin.
    Type: Application
    Filed: May 4, 2012
    Publication date: December 20, 2012
    Applicants: Novozymes Biopharma UK Limited, Novozymes Biopharma DK A/S, Novozymes A/S, University of Oslo
    Inventors: Jan Terje Andersen, Bjorn Dalhus, Inger Sandlie, Jason Cameron, Andrew Plumridge, Esben Peter Friis, Karen Delahay
  • Publication number: 20120220530
    Abstract: The present invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The present invention also relates to fusion polypeptides and conjugates comprising said variant albumin.
    Type: Application
    Filed: November 1, 2010
    Publication date: August 30, 2012
    Applicant: Novozymes Biopharma DK A/S
    Inventors: Andrew Plumridge, Darrell Sleep, Jason Cameron, Inger Sandlie, Jan Terje Andersen, Esben Peter Friis